SCHEMBL8105331

SCHEMBL8105331

CC(=O)Cc1cccc(CN)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS1 P29475 4/20 0.53
NOS2 P35228 4/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
ALDH1A1 P00352 2/20 0.53
NOS3 P29474 2/20 0.53
CYP3A4 P08684 1/20 0.53
NFKB1 P19838 1/20 0.53
LOXL2 Q9Y4K0 3/20 0.51
ENPP2 Q13822 1/20 0.50
GLS O94925 2/20 0.46
PNMT P11086 1/20 0.45
SLC7A5 Q01650 1/20 0.44
CYP2D6 P10635 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
TSHR P16473 1/20 0.43
CYP2C19 P33261 1/20 0.43
CFD P00746 1/20 0.43
KLKB1 P03952 1/20 0.43
KLK1 P06870 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6509671 0.89 ALDH1A1 (0.46) ALDH1A1SLC7A5CYP1A2CYP2C19
SCHEMBL29351393 0.84 CA2 (0.45) NOS1NOS2SMN1; SMN2ALDH1A1NOS3
SCHEMBL22265815 0.84 CA2 (0.45) NOS1NOS2SMN1; SMN2ALDH1A1NOS3
SCHEMBL28307894 0.83 ENPP2 (0.54) NOS1NOS2SMN1; SMN2ALDH1A1NOS3
SCHEMBL11079658 0.83 KDM4E (0.52) NOS1NOS2SMN1; SMN2NOS3LOXL2
SCHEMBL12081708 0.83 SMN1; SMN2 (0.38) NOS1NOS2SMN1; SMN2ALDH1A1NOS3
SCHEMBL13905068 0.82 BCL2 (0.47) SMN1; SMN2ALDH1A1SLC7A5CYP1A2TSHR
SCHEMBL3803115 0.82 AKR1B1 (0.58) NOS1NOS2SMN1; SMN2ALDH1A1NOS3
SCHEMBL7770968 0.82 ENPP2 (0.52) NOS1NOS2SMN1; SMN2ALDH1A1NOS3
SCHEMBL13554933 0.82 ENPP2 (0.44) SMN1; SMN2ALDH1A1ENPP2SLC7A5TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017189342-A1 INSULIN DIMER-INCRETIN CONJUGATES MERCK SHARP & DOHME CORP. (US) 2017-11-02 WO disclosed
WO-2017160669-A1 INSULIN-INCRETIN CONJUGATES MERCK SHARP & DOHME CORP. (US) 2017-09-21 WO disclosed
CN-101107247-B Substituted benzoquinolizines as dpp-iv inhibitors for the treatment of diabetes HOFFMANN LA ROCHE 2011-10-19 CN disclosed
CN-101107247-A Substituted benzoquinolizines as dpp-iv inhibitors for the treatment of diabetes HOFFMANN LA ROCHE (CH) 2008-01-16 CN disclosed
EP-0716661-B1 PSEUDO- AND NON-PEPTIDE BRADYKININ RECEPTOR ANTAGONISTS SCIOS INC (US) 2000-04-05 EP disclosed
US-5552383-A ANALGESIC, ANTIINFLAMMATORY FOR WOUNDS SCIOS NOVA INC. (US) 1996-09-03 US disclosed
US-5541286-A Bradykinin antagonist pseudopeptide derivatives of olefinic aminoalkanoic acids SCIOS NOVA INC. (US) 1996-07-30 US disclosed
EP-0716661-A1 PSEUDO- AND NON-PEPTIDE BRADYKININ RECEPTOR ANTAGONISTS SCIOS NOVA INC. (US) 1996-06-19 EP disclosed
WO-1995007294-A1 PSEUDO- AND NON-PEPTIDE BRADYKININ RECEPTOR ANTAGONISTS SCIOS NOVA INC. (US) 1995-03-16 WO disclosed